{"database": "press", "table": "releases", "rows": [["https://www.rickscott.senate.gov/2025/10/in-case-you-missed-it-sen-rick-scott-leads-investigate-report-on-dangerous-overreliance-on-foreign-made-generic-drugs-this-report-is-just-the-beginning", "IN CASE YOU MISSED IT\u2026 Sen. Rick Scott Leads Investigate Report on Dangerous Overreliance on Foreign-Made Generic Drugs: \u2018This Report is Just the Beginning\u2019", "2025-10-22", "2025", "2025-10", "Republican", "Senate", "FL", "Rick Scott", "S001217", "www.rickscott.senate.gov", "rickscott", "https://www.rickscott.senate.gov/press-releases/", "page_html", "WASHINGTON, D.C. \u2013 In case you missed it, Senator Rick Scott as chairman of the U.S. Senate Special Committee on Aging, released an investigative report titled \u201cProtecting Seniors\u2019 Access to Essential Medications: Securing the Foreign Generic Pharmaceutical Supply Chain.\u201d The report is aimed at America\u2019s severely dangerous overreliance on foreign-made generic drugs, which are vastly imported from Communist China and India.\n\nThis comes after Senator Scott held a hearing exposing the direct national security and public health threats caused by this horrific overdependence on foreign-made generic drugs and their ingredients. In a second hearing, the Aging Committee again heard from expert witnesses who discussed recommendations to secure America\u2019s pharmaceutical supply chains and ensure access to high-quality, life-saving generic drugs that millions of Americans \u2013 including those in our aging community \u2013 rely on. More recently, the senator also wrote an op-ed for The Hill, discussing the threat in detail.\n\nSenator Rick Scott said, \u201cThe United States\u2019 overreliance on foreign-made generic drugs, especially those made in adversarial nations, is a very real threat to all Americans, but especially our aging population. Not only have we had many recorded cases of these imported, generic drugs being contaminated and causing death and injury, if Communist China, our adversary, or India shut off the flow of these essential drugs, the U.S. would only have months of prescription drug supply, forcing us to begin rationing drugs and turning away all but the most in need within a matter of weeks! Our seniors deserve better, and this report is just the beginning as we expose this national security and public health crisis and how to fix it by increasing Food and Drug Administration oversight and bringing generic drug production back to America. Congress has to work with the Trump administration and act now to make sure that Americans have safe and high-quality drugs and to secure the prescription drug supply chain.\u201d\n\nHighlights of the report include:\n\nThe U.S. manufactured 37% of its consumed pharmaceuticals in 2024, a stark decline from 2002 when that figure was at 83%.\n\nChina accounts for 95% of U.S. imports of ibuprofen, 70% of U.S. imports of acetaminophen, and upwards of 45% of U.S. imports of penicillin.\n\nApproximately 90% of the Active Pharmaceutical Ingredients (APIs) for global antibiotics are of Chinese origin, and 83% of the top 100 generic drugs consumed by U.S. citizens have no U.S.-based source of APIs.\n\nWhile India supplies approximately 50% of all generic drugs used in the U.S., Indian manufacturers rely heavily on China for approximately 80% of the API that they use.\n\nAccording to a 2025 study, the occurrence of serious adverse events for generic drugs manufactured in India was 54% higher than for equivalent drugs that were manufactured in the United States. Adverse events were hospitalization, disability, and death.\n\nThe report also recommends the following solutions:\n\nEstablish a federal buyer\u2019s market for essential medicines, prioritizing American made products first, and prioritizing near- and friend-shoring if American made products are not available;\n\nMap our generic drug supply chains;\n\nRequire companies to disclose country of origin for finished pharmaceuticals;\n\nUtilize trade levers like the administration\u2019s 232 investigation authority;\n\nPass clarifying language to close loopholes that allow foreign-made products to be categorized as \u2018Made in America;\u2019 and\n\nSupport U.S. biotechnology\n\nRead the full report HERE or by clicking the image below.\n\n###", 1, "2026-03-30T01:40:41Z", "2026-03-30T11:08:25Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.rickscott.senate.gov/2025/10/in-case-you-missed-it-sen-rick-scott-leads-investigate-report-on-dangerous-overreliance-on-foreign-made-generic-drugs-this-report-is-just-the-beginning"], "units": {}, "query_ms": 1.7239840235561132, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}